Tecnologia em Saúde
Empresas Argentinas envolvidas em um setor: tecnologia em saúde
Essas Empresas Argentinas operam no mesmo setor, tecnologia em saúde. Elas estão equipadas com preço, variação e outras estatísticas para ajudá-lo a obter o máximo de detalhes. A lista contém ações para qualquer estratégia: gigantes com grandes valores de mercado, como ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1, empresas com os maiores ganhos, como INTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORD, e muito mais. Filtre a lista e verifique o desempenho das empresas de maneira conveniente.
Símbolo | Valor de mercado | Preço | Variação % | Volume | Volume Rel | P/L | EPS dil TTM | Crescimento EPS dil. 12M Ano a Ano | Div. yield % TTM | Classificação dos Analistas |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 787,72 T ARS | 16.925,000 ARS | +2,11% | 7,29 K | 1,75 | 135,56 | 124,85 ARS | +564,33% | 0,32% | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 787,72 T ARS | 14,600 USD | +1,74% | 457 | 1,29 | 113,31 | 124,85 ARS | +178,70% | 0,32% | — |
 DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)DR | 354,8 T ARS | 1.300,000 ARS | 0,00% | 81 | 8,62 | — | — | — | — | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 354,8 T ARS | 11.300,000 ARS | 0,00% | 22,05 K | 0,50 | 36,82 | 306,92 ARS | +257,75% | 1,73% | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 354,8 T ARS | 9,950 USD | −1,97% | 2,15 K | 1,11 | 31,41 | 306,92 ARS | +50,08% | 1,73% | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 321,11 T ARS | 20.775,000 ARS | −0,24% | 690 | 0,52 | 8,87 | 2.343,37 ARS | +183,01% | 1,69% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 321,11 T ARS | 17,350 USD | −7,22% | 51 | 0,64 | 7,17 | 2.343,37 ARS | +18,73% | 1,69% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 260,44 T ARS | 23.675,000 ARS | +1,39% | 715 | 0,24 | 26,80 | 883,37 ARS | +899,22% | 1,58% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 260,44 T ARS | 20,200 USD | −2,18% | 5 | 0,11 | 22,16 | 883,37 ARS | +319,19% | 1,58% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 217,31 T ARS | 39.775,000 ARS | +1,79% | 1,09 K | 0,77 | 58,68 | 677,80 ARS | +291,99% | 1,44% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 217,31 T ARS | 34,200 USD | +0,29% | 146 | 10,74 | 48,89 | 677,80 ARS | +64,44% | 1,44% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 215,18 T ARS | 29.475,000 ARS | −0,67% | 502 | 4,37 | 52,73 | 558,94 ARS | +251,94% | 0,16% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 205,09 T ARS | 29.575,000 ARS | −0,76% | 375 | 1,63 | 3,41 | 8.672,72 ARS | +474,20% | 3,62% | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 205,09 T ARS | 25,400 USD | +1,60% | 20 | 14,29 | 2,84 | 8.672,72 ARS | +140,89% | 3,62% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 202,28 T ARS | 7.360,000 ARS | +6,82% | 241 | 4,18 | 139,16 | 52,89 ARS | +386,62% | 0,00% | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 202,07 T ARS | 33.400,000 ARS | +0,45% | 3,54 K | 3,43 | 53,02 | 629,98 ARS | +270,79% | 0,93% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 202,07 T ARS | 29,400 USD | −0,17% | 45 | 1,80 | 45,22 | 629,98 ARS | +55,55% | 0,93% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 176,13 T ARS | 5.190,000 ARS | −0,76% | 88 | 0,16 | 70,36 | 73,76 ARS | +137,74% | 0,19% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 157,08 T ARS | 7.980,000 ARS | −0,50% | 61,07 K | 2,85 | 34,00 | 234,71 ARS | +224,10% | 3,10% | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 157,08 T ARS | 7,000 USD | +0,43% | 1,18 K | 1,26 | 28,90 | 234,71 ARS | +35,96% | 3,10% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 146,22 T ARS | 10.375,000 ARS | −2,81% | 10,47 K | 12,23 | 41,65 | 249,09 ARS | +18,17% | 2,36% | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 117,46 T ARS | 22.225,000 ARS | −5,43% | 886 | 1,64 | — | −1.078,84 ARS | −466,33% | 2,08% | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD DR | 117,46 T ARS | 19,200 USD | 0,00% | 6 | 0,77 | — | −1.078,84 ARS | −253,68% | 2,08% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 116,2 T ARS | 26.400,000 ARS | +3,83% | 184 | 0,23 | — | −50,65 ARS | −118,38% | 1,72% | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 116,2 T ARS | 25,100 USD | +2,03% | 7 | 0,65 | — | −50,65 ARS | −107,71% | 1,72% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 107,29 T ARS | 24.100,000 ARS | −6,95% | 596 | 0,49 | 35,84 | 672,48 ARS | +274,72% | 2,28% | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 70,28 T ARS | 9.850,000 ARS | −4,37% | 2,46 K | 2,27 | 32,00 | 307,84 ARS | +49,45% | 3,32% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 70,28 T ARS | 8,540 USD | +0,47% | 230 | 8,27 | 26,88 | 307,84 ARS | −37,30% | 3,32% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 25,22 T ARS | 6.200,000 ARS | +3,51% | 101 | 0,30 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 22,5 T ARS | 13.500,000 ARS | −0,37% | 1,34 K | 3,23 | 19,41 | 695,64 ARS | +368,68% | 0,00% | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 22,5 T ARS | 12,300 USD | 0,00% | 61 | 5,92 | 17,13 | 695,64 ARS | +96,62% | 0,00% | — |
 MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORDDR | 16,87 T ARS | 2.665,000 ARS | −3,09% | 38,44 K | 1,68 | — | −262,17 ARS | −63,54% | 0,00% | — |
| MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 16,87 T ARS | 2,180 USD | +0,46% | 4 | 0,02 | — | −262,17 ARS | +31,39% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 140,91 B ARS | 1.745,000 ARS | 0,00% | 12,59 K | 0,73 | 18,12 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,05 B ARS | 118,500 ARS | 0,00% | 843 | 0,09 | 27,76 | 4,27 ARS | +64,50% | 0,00% | — |